وثيقة
Cost-effectiveness of IGRA/QFT-Plus for TB screening of migrants in Oman.
المعرف
DOI: 10.1016/j.ijid.2020.03.010
المصدر
International Journal of Infectious Diseases. v. 92, p. S72-S77
المساهمون
Kowada, Akiko., مؤلف
Yaqoubi, Fatma., مؤلف
Al-Khaliliyah, Sulien., مؤلف
Ndunda, Nduku., مؤلف
Petersen, Eskild., مؤلف
الدولة
Netherlands.
مكان النشر
Amsterdam
الناشر
Elsevier B.V.
ميلادي
2020-03-01
اللغة
الأنجليزية
الموضوع
الملخص الإنجليزي
Objective: To estimate the cost of a screening program for identifying latent tuberculosis (TB) infections in migrants to Oman. Methods: A Markov model was used to estimate the cost of screening using an interferon-gamma release assay (IGRA) applied to all migrants from high TB endemic countries, followed by preventive TB treatment. Results: The model compared seven different scenarios, with a comparison of the direct cost and the quality-adjusted life-years (QALYs) saved. Conclusions: IGRA testing followed by 3 months of preventive treatment with rifapentine/isoniazid (3HP) was the most cost-effective intervention.
ISSN
1201-9712
قالب العنصر
مقالات الدوريات